| P2093 | author name string | Charles H Banov | |
| P2860 | cites work | Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma | Q28328440 |
| | Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years | Q28360535 |
| | Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma | Q28368979 |
| | Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data | Q32143825 |
| | Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis | Q33634936 |
| | Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients | Q33775866 |
| | Once-daily inhaled corticosteroids in mild to moderate asthma: improving acceptance of treatment | Q33860030 |
| | Once-daily inhaled corticosteroids in children with asthma: nebulisation | Q33860044 |
| | Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders | Q34112928 |
| | Inhaled corticosteroids reduce growth. Or do they? | Q34239341 |
| | Do inhaled corticosteroids inhibit growth in children? | Q34345371 |
| | Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma | Q34592943 |
| | Growth of asthmatic children during treatment with budesonide: a double blind trial | Q35180079 |
| | Use of inhaled corticosteroids and the risk of cataracts. | Q39448051 |
| | A comparison of the efficacy and safety of inhaled corticosteroids in asthma | Q41559651 |
| | Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma | Q41669268 |
| | Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children | Q41693586 |
| | Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate | Q42289291 |
| | The risk of cataract among users of inhaled steroids | Q43541134 |
| | Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma | Q43655193 |
| | Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids | Q43655195 |
| | High or standard initial dose of budesonide to control mild-to-moderate asthma? | Q43697561 |
| | The inhaled Steroid Treatment as Regular Therapy in early asthma (START) study: rationale and design | Q43713633 |
| | A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma | Q43880002 |
| | Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma | Q44161807 |
| | Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial | Q44388200 |
| | Adrenal function in asthmatic children treated with inhaled budesonide | Q44466992 |
| | Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma | Q44508643 |
| | A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants | Q46206581 |
| | Effect of long-term treatment with inhaled budesonide on adult height in children with asthma | Q47227706 |
| | Reduced height in swedish men with asthma at the age of conscription for military service | Q47234883 |
| | Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma | Q48091910 |
| | Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study | Q48497000 |
| | Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease | Q49083880 |
| | Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group | Q49092631 |
| | Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. | Q50601836 |
| | Prolonged airway activity and improved selectivity of budesonide possibly due to esterification. | Q50758361 |
| | Association of inhaled corticosteroid use with cataract extraction in elderly patients. | Q50870339 |
| | Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study. | Q50932484 |
| | Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. | Q51598109 |
| | A prospective evaluation of the adequacy of peak inspiratory flow rates and validation of the Turbutester score in asthmatic individuals with "low" peak expiratory flow rates: implications for dry powder inhalers. | Q51681758 |
| | Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics. | Q52899269 |
| | Long-term effects of budesonide or nedocromil in children with asthma. | Q53809666 |
| | Body composition and growth in asthmatic children treated with inhaled steroids. | Q53903346 |
| | Systemic activity of inhaled topical steroid in toddlers studied by knemometry | Q57638479 |
| | Once-daily budesonide in mild asthma | Q59361839 |
| | Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy | Q63740333 |
| | Chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy | Q63740336 |
| | Pneumonia in intubated trauma patients. Microbiology and outcomes | Q70838982 |
| | Effect of Early vs Late Intervention With Inhaled Corticosteroids in Asthma | Q71810384 |
| | Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma | Q72072586 |
| | Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma | Q72123963 |
| | Local side-effects during 4-year treatment with inhaled corticosteroids--a comparison between pressurized metered-dose inhalers and Turbuhaler | Q72140842 |
| | Budesonide treatment of moderate and severe asthma in children: a dose-response study | Q72412141 |
| | Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids | Q72523802 |
| | Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group | Q73076882 |
| | Efficacy of once-daily versus twice-daily administration of budesonide by Turbuhaler(R) in children with stable asthma | Q73118634 |
| | Association between intraocular pressure and budesonide inhalation therapy in asthmatic patients | Q73255151 |
| | Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma | Q73445017 |
| | Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study | Q73526698 |
| | The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis | Q73948325 |
| | Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide | Q74100430 |
| | Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma | Q74215781 |
| | Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma | Q74493310 |
| | Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma | Q74642909 |
| | Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids | Q77152862 |
| | Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma | Q77569810 |
| | Adverse effects of inhaled budesonide (800 micrograms) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration | Q77577089 |
| | Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids | Q77720145 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 5-17 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Journal of Asthma | Q2603603 |
| P1476 | title | The role of budesonide in adults and children with mild-to-moderate persistent asthma | |
| P478 | volume | 41 | |